OncoAssure Prostate Cancer Test

About OncoAssure

OncoAssure is a private, pre-revenue diagnostics company developing precision oncology tests, with an initial focus on prostate cancer. The company leverages a proprietary process combining transcriptomics and mathematical modeling to identify key drivers of cancer progression and generate prognostic biomarkers. With a management team experienced in diagnostic development and commercialization—including a prior successful exit via acquisition by Cepheid—OncoAssure is advancing its lead test through clinical validation and U.S. launch activities while seeking further investment.

Therapeutic Areas

Other Prostate Cancer Prognosis Drugs